Marosi C - Search Results

1

The caregivers' perspective on the end-of-life phase of glioblastoma patients.

Flechl B, Ackerl M, Sax C, Oberndorfer S, Calabek B, Sizoo E, Reijneveld J, Crevenna R, Keilani M, Gaiger A, Dieckmann K, Preusser M, Taphoorn MJ, Marosi C. Flechl B, et al. Among authors: marosi c. J Neurooncol. 2013 May;112(3):403-11. doi: 10.1007/s11060-013-1069-7. Epub 2013 Feb 15. J Neurooncol. 2013. PMID: 23412776

2

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

Valencak J, Dietrich W, Raderer M, Dieckmann K, Prayer D, Hainfellner JA, Marosi C. Valencak J, et al. Among authors: marosi c. J Neurooncol. 2000 Sep;49(3):263-8. doi: 10.1023/a:1006405106553. J Neurooncol. 2000. PMID: 11212906 Review.

3

Prognostic relevance of p53 protein expression in glioblastoma.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ungersböck K, Rössler K, Budka H, Hainfellner JA. Birner P, et al. Among authors: marosi c. Oncol Rep. 2002 Jul-Aug;9(4):703-7. Oncol Rep. 2002. PMID: 12066196

4

[Aerobic physical training in a breast cancer patient with inflammatory recurrence].

Crevenna R, Fialka-Moser V, Keilani MY, Schmidinger M, Marosi C, Quittan M. Crevenna R, et al. Among authors: marosi c. Wien Med Wochenschr. 2002;152(21-22):581-4. doi: 10.1046/j.1563-258x.2002.01135.x. Wien Med Wochenschr. 2002. PMID: 12506684 German.

5

Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme.

Piribauer M, Fazeny-Dörner B, Rössler K, Ungersböck K, Czech T, Killer M, Dieckmann K, Birner P, Prayer D, Hainfellner J, Muhm M, Marosi C. Piribauer M, et al. Among authors: marosi c. Anticancer Drugs. 2003 Feb;14(2):137-43. doi: 10.1097/00001813-200302000-00007. Anticancer Drugs. 2003. PMID: 12569300 Clinical Trial.

6

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

Fazeny-Dörner B, Veitl M, Wenzel C, Rössler K, Ungersböck K, Dieckmann K, Piribauer M, Hainfellner J, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Br J Cancer. 2003 Feb 24;88(4):496-501. doi: 10.1038/sj.bjc.6600769. Br J Cancer. 2003. PMID: 12592361 Free PMC article. Clinical Trial.

7

Survival and prognostic factors of patients with unresectable glioblastoma multiforme.

Fazeny-Dörner B, Wenzel C, Veitl M, Piribauer M, Rössler K, Dieckmann K, Ungersböck K, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Anticancer Drugs. 2003 Apr;14(4):305-12. doi: 10.1097/00001813-200304000-00008. Anticancer Drugs. 2003. PMID: 12679735

8

Psychometric- and quality-of-life assessment in long-term glioblastoma survivors.

Schmidinger M, Linzmayer L, Becherer A, Fazeny-Doemer B, Fakhrai N, Prayer D, Killer M, Ungersboeck K, Dieckmann K, Marosi C. Schmidinger M, et al. Among authors: marosi c. J Neurooncol. 2003 May;63(1):55-61. doi: 10.1023/a:1023740303162. J Neurooncol. 2003. PMID: 12814255

9

[Aerobic endurance training for cancer patients].

Crevenna R, Zielinski C, Keilani MY, Schmidinger M, Bittner C, Nuhr M, Nur H, Marosi C, Fialka-Moser V, Quittan M. Crevenna R, et al. Among authors: marosi c. Wien Med Wochenschr. 2003;153(9-10):212-6. doi: 10.1046/j.1563-258x.2003.02080.x. Wien Med Wochenschr. 2003. PMID: 12836458 Review. German.

10

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.

Fazeny-Dörner B, Veitl M, Wenzel C, Piribauer M, Rössler K, Dieckmann K, Ungersböck K, Marosi C. Fazeny-Dörner B, et al. Among authors: marosi c. Anticancer Drugs. 2003 Jul;14(6):437-42. doi: 10.1097/00001813-200307000-00008. Anticancer Drugs. 2003. PMID: 12853885 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters